Evidence map›Paper›PMID 40656027›Full record

ArticleFrontiers in child and adolescent psychiatry2025

The Youth Risk Index: psychometrics, predicting the initiation of early adolescent substance use, and the breadth of liability detected.

Ty A Ridenour, Nisha O'Shea Gottfredson, Jason Williams, Daniel S Shaw, Maureen D Reynolds, Cheryl A Roberts, Richard Spoth, David R Garnica-Agudelo, Idil Baran, Aysenil Belger and 1 more

Abstract read
In one paragraph

Article in Frontiers in child and adolescent psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ty A RidenourSubstance Use Prevention, Evaluation, and Research, RTI International, Research Triangle Park, NC, United States.
Nisha O'Shea GottfredsonSubstance Use Prevention, Evaluation, and Research, RTI International, Research Triangle Park, NC, United States.
Jason WilliamsSubstance Use Prevention, Evaluation, and Research, RTI International, Research Triangle Park, NC, United States.
Daniel S ShawDepartment of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, United States.
Maureen D ReynoldsDepartment of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA, United States.
Cheryl A RobertsSubstance Use Prevention, Evaluation, and Research, RTI International, Research Triangle Park, NC, United States.
Richard SpothPartnerships in Prevention Science Institute, Iowa State University, Ames, IA, United States.
David R Garnica-AgudeloFrank Porter Graham Child Development Institute, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States.
Idil BaranFrank Porter Graham Child Development Institute, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States.
Aysenil BelgerFrank Porter Graham Child Development Institute, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States.
Diana H FishbeinFrank Porter Graham Child Development Institute, University of North Carolina, Chapel Hill, Chapel Hill, NC, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Over the last two decades, drug use epidemics have occurred across the world, including in countries with well-funded services for treatment and recovery, underscoring the need to bolster primary prevention. Moreover, substance use (SU) and SU disorders (SUDs) contribute to the etiology and exacerbation of many medical and psychiatric illnesses. The first step in providing selective/indicated prevention for SU/SUD is identifying high liability (overall risk). We evaluated the Methods: Using data from five previously recruited samples of youth, psychometric analyses consisted of (1) confirmatory factor analyses comparing two latent structures, (2) non-invariance tests between sexes and purposes for using the YRI (research or screening), and (3) concurrent and predictive validity. Reports from 4,495 youths aged 8-13 were analyzed, with approximately half of the sample representing each sex, each research purpose, and a Caucasian identity. Results: A latent structure with one second-order factor (Overall Liability) and three first-order factors (Disinhibition, Peer Conduct Problems, and Social Contagion) best fit the observed data and was well-replicated within sexes and purposes. Partial scalar non-invariance between purposes occurred for Overall Liability involving two items. Disinhibition had partial non-invariance between sexes and purposes involving the same item. Greater non-invariance was found for Peer Conduct Problems and Social Contagion. Traditional and non-invariance-adjusted scores correlated highly, with values of 0.96 for Overall Liability, 0.99 for Disinhibition, 0.89 for Peer Conduct Problems, and 0.93 for Social Contagion. Traditional scoring provided a good to excellent area under the receiving operating characteristic curve for concurrent and 1-year SU and conduct problems. Greater YRI scores were associated with greater youth-reported depression, sensation seeking, substance use, conduct disorder behaviors, and parental problems from SU and/or legal problems, as well as less self-management and parent fortification and poorer performances in planning, problem-solving, and low-load working memory tasks. YRI scores correlated less with parent reports on youths than with youth self-reports. Discussion: In sum, YRI scores encapsulate many segments of risk for SU/SUD and related behavior problems, which is critical to accurately identify the need for and provision of selective/indicated prevention because of the manifold risk factors for, and complex etiology of, SU/SUD.

Indexed as

conduct problemsdisinhibitionscreeningsocial contagionsubstance use and misusesubstance use disorder liabilityvalidity

Identifiers

PMID40656027
PMCPMC12245781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.